Skip to main content
OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc. — Investor Relations & Filings

Ticker · 4564 ISIN · JP3202150003 LEI · 529900CIAZCAIG781H52 T Professional, scientific and technical activities
Open in API
Filings indexed 66 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country JP Japan
Listing T 4564

About OncoTherapy Science, Inc.

https://www.oncotherapy.co.jp/en/

OncoTherapy Science, Inc. is a biopharmaceutical company focused on the research and development of novel anti-cancer therapies. The company utilizes cancer-specific gene data and comprehensive cancer genome analysis to discover and develop molecular-targeted drugs, antibody drugs, cancer vaccines, and new immunotherapies. Its key technological focuses include liquid biopsy, neoantigen prediction, and T-cell receptor (TCR) repertoire analysis using next-generation sequencing. The company's primary objective is to develop highly effective cancer treatments with minimal adverse events and side effects for patients.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 87% confidence The document is a Japanese “臨時報告書” (Timely Report) filed under the Financial Instruments and Exchange Act, announcing the proposed change of the company’s statutory auditor (audit firm) at the upcoming shareholders’ meeting. It is not an annual or interim financial report nor an audit opinion itself, nor is it a management/board change or dividend notice. It is a specific regulatory disclosure (ad hoc event) and thus falls under the general Regulatory Filings category (RNS).
2026-05-19 Japanese
公認会計士等の異動に関するお知らせ
Regulatory Filings
2026-05-19 Japanese
有価証券届出書（組込方式）
Share Issue/Capital Change Classification · 100% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by OncoTherapy Science, Inc. It details a third-party allotment of shares and stock acquisition rights (warrants). This type of filing is a formal regulatory document required for capital raising activities in Japan, which falls under the 'Share Issue/Capital Change' category.
2025-11-21 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a semi-annual report. H1 2025
2025-11-10 Japanese
半期報告書－第25期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management discussion and analysis (MDA), and business status updates for the six-month period ending September 30, 2025. As it is a formal, comprehensive financial report for an interim period, it falls under the 'Interim / Quarterly Report' category. H1 2026
2025-11-10 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being submitted following the resolution of matters at the Annual General Meeting (AGM) held on June 24, 2025, based on Japanese financial regulations (FIEA Article 24-5(4)). Section 2 details the resolutions passed, specifically regarding a change in the authorized number of shares (capital structure) and the election of an auditor, along with the voting results (For/Against/Abstain). This structure—reporting the results of a shareholder meeting—is characteristic of a filing announcing the outcome of an AGM or EGM. Since the document reports the official results of shareholder votes, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, DVA specifically covers the *results* of the vote, whereas AGM-R is typically for the presentation materials themselves.
2025-06-26 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.